LGALS3 and Tetralogy of Fallot: Galectin-3 is a strong predictor of poor prognosis in the early follow up after surgery in children treated for such congenital heart diseases as a ventricular septal defect, atrioventricular septal defect or pulmonary valve regurgitation after tetralogy of Fallot repair [25].